Diagnostic Challenges: From Atypical Ductal Hyperplasia to Ductal Carcinoma In Situ

This track focuses on the diagnostic challenges encountered in the spectrum of breast lesions, specifically from atypical ductal hyperplasia (ADH) to ductal carcinoma in situ (DCIS). With the increasing use of and detection techniques, the identification and accurate diagnosis of these lesions have become crucial for appropriate patient management. This track explores the complexities involved in distinguishing between ADH and DCIS, discussing the overlapping morphological features, immunohistochemical markers, and molecular characteristics that aid in differential diagnosis. The track also highlights the latest advancements in diagnostic tools, including genomic profiling and molecular testing, aiming to enhance diagnostic accuracy and guide optimal treatment strategies for patients with ADH and DCIS.

  • Histopathological Evaluation: Morphological Criteria and Interpretation Challenges
  • Radiological-Pathological Correlation: Enhancing Diagnostic Accuracy
  • Biomarkers and Molecular Profiling: Identifying High-Risk Lesions
  • Management Dilemmas: Overdiagnosis and Overtreatment
  • Emerging Techniques and Technologies: Improving Diagnostic Precision

Related Conference of Diagnostic Challenges: From Atypical Ductal Hyperplasia to Ductal Carcinoma In Situ

December 14-15, 2023

5th International Conference on Oncology and Cancer

Rome, Italy
February 22-23, 2024

14th World Congress on Breast Cancer

Zurich, Switzerland
March 18-19, 2024

5th Global Summit on Oncology and Hematology

Zurich, Switzerland
March 21-22, 2024

8th Global Meeting on Oncology and Radiology

Paris, France
April 18-19, 2024

24th World Congress on Cancer and Diagnostics

Dubai, UAE

Diagnostic Challenges: From Atypical Ductal Hyperplasia to Ductal Carcinoma In Situ Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in